Alumis (ALMS) Profit After Tax (2023 - 2025)
Alumis' (ALMS) quarterly Profit After Tax came in at -$324.9 million in Q4 2025, down 242.84% year-on-year from $227.4 million in Q4 2024, and down 193.33% on a QoQ basis from -$110.8 million in Q3 2025.
Alumis (ALMS) Profit After Tax (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Profit After Tax data on file, last reported at -$324.9 million in Q4 2025.
- On a quarterly basis, Profit After Tax fell 242.84% year-over-year to -$324.9 million in Q4 2025; TTM through Dec 2025 was -$475.3 million, a 38.65% decrease from a year earlier, with the FY2025 full-year figure at -$475.1 million, down 61.46% from the prior year.
- Profit After Tax for Q4 2025 stood at -$324.9 million, down from -$110.8 million in the prior quarter.
- Over the last five years, Profit After Tax for ALMS reached as high as $59.3 million in Q2 2025 and fell as low as -$324.9 million in Q4 2025.
- Historically, Profit After Tax has averaged -$85.2 million across 3 years, with a median of -$56.5 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 204.98% in 2025 and fell as far as 242.84% in 2025.
- Year by year, Profit After Tax stood at -$39.3 million in 2023, then sank by 141.07% to -$94.8 million in 2024, then plunged by 242.84% to -$324.9 million in 2025.
- Per Business Quant data, the three most recent Profit After Tax figures were -$324.9 million in Q4 2025, -$110.8 million in Q3 2025, and $59.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Alumis | 2.41 Bn | 2.10 Bn | - | -324.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -324.87 Mn |
| Sep 30, 2025 | -110.75 Mn |
| Jun 30, 2025 | 59.32 Mn |
| Mar 31, 2025 | -98.96 Mn |
| Dec 31, 2024 | -94.76 Mn |
| Sep 30, 2024 | -141.67 Mn |
| Jun 30, 2024 | -56.51 Mn |
| Mar 31, 2024 | -49.85 Mn |
| Dec 31, 2023 | -39.31 Mn |
| Sep 30, 2023 | -43.38 Mn |
| Jun 30, 2023 | -36.29 Mn |